Laparoscopic microwave ablation of liver tumors: Our experience

Hepato-Gastroenterology

Volumn 55, Issue 81, 2008, Pages 27-32

  Jagad, Rajan B ^a   Koshariya, Mahim ^a   Kawamoto, Jun ^a   Papastratis, P ^a   Kefalourous, H ^a   Patris, V ^a   Porfiris, T ^a   Gevrielidis, Pascailis ^a   Tzouma, Christina ^a   Lygidakis, N J ^a,b  

^a ATHENS MEDICAL CENTER   (Greece)

^b NONE   (Greece)

Author keywords

Laparoscopy; Liver tumors; Microwave ablation

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION; CANCER PATIENT; CANCER THERAPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPIC MICROWAVE ABLATION; LAPAROSCOPY; LIVER ABSCESS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SAFETY; TUMOR NECROSIS;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEASIBILITY STUDIES; FEMALE; HUMANS; LAPAROSCOPY; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; NECROSIS; RETROSPECTIVE STUDIES;

EID: 41549142687     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Safioleas M, Lygidakis NJ, Manti C: Hepatitis B today. Hepatogastroenterology 2007; 54(74):545-548.
2. Kountouras J, Lygidakis NJ: New epidemiological data on liver oncogenesis. Hepatogastroenterology 2000; 47(33):855-861.
3. Hirai I, Kimura W, Fuse A, et al: Surgical management for metastatic liver tumors. Hepatogastroenterology 2006; 53(71):757-763.
4. Hamy AP, Paineau JR, Mirallie EC, et al: Hepatic resections for non-colorectal metastases: forty resections in 35 patients. Hepatogastroenterology 2000; 47(34):1090-1094.
5. Nuzzo G, Giuliante F, Giovannini I, et al: Resection of hepatic metastases from colorectal cancer. Hepatogastroenterology 1997; 44(15):751-759.
6. Foster JH: Surgical treatment of metastatic liver tumors. Hepatogastroenterology 1990; 37(2):182-118.
7. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM: Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997; 132:505-510.
8. Weber SM, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y: Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000; 7:643-650.
9. Cha C, Lee FT Jr, Rikkers LF, Niederhuber JE, Nguyen BT, Mahvi DM: Rationale for the combination of cryoablation with surgical resection of hepatic tumors. J Gastrointest Surg 2001; 5:206-213.
10. Rees M, John TG: Current status of surgery in colorectal metastases to the liver. Hepatogastroenterology 2001; 48:341-344.
11. Nicoli N, Casaril A, Mangiante G, Ciola M, Hilal MA, Marchiori L: Surgical treatment for liver metastases from colorectal carcinoma: results of 228 patients. Hepatogastroenterology 2004; 51(60):1810-1814.
12. Jain S, Sacchi M, Vrachnos P, Lygidakis NJ, Andriopoulou E: Recent advances in the treatment of colorectal liver metastases. Hepatogastroenterology 2005; 52(65): 1567-1584.
13. Lygidakis NJ, Bhagat AD, Vrachnos P, Grigorakos L: Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases - newer multimodality approach. Hepatogastroenterology 2007; 54(76):1020-1024.
14. Lygidakis NJ, Singh G, Bardaxoglou E, et al: Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. Hepatogastroenterology 2004; 51(56):413-418.
15. Lygidakis NJ, Singh G, Bardaxoglou E, et al: New frontiers in the management of advanced hepatocellular carcinoma. "A new look to an old problem". Hepatogastroenterology 2004; 51(55):62-67.
16. Lygidakis NJ, Sgourakis G, Vlachos L, et al: Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study. Hepatogastroenterology 2001; 48(42):1685-1691.
17. Lygidakis NJ, Sgourakis G, Dedemadi G, et al: Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study. Hepatogastroenterology 2001; 48(40):1085-1087.
18. Lygidakis NJ, Sgourakis G, Dedemadi G, et al: Preoperative main portal branch transection combined with liver locoregional transarterial neo and adjuvant immunochemotherapy for patients with hepatocellular carcinoma. Hepatogastroenterology 2000; 47(36):1546-1554.
19. Lygidakis NJ, Vlachos L, Raptis S, et al: New frontiers in liver surgery. Two-stage liver surgery for the management of advanced metastatic liver disease. Hepatogastroenterology 1999; 46(28):2216-2228.
20. Lygidakis NJ: Unresectable metastatic liver disease: new therapeutical alternatives. Hepatogastroenterology 1999; 46(1):1297-1305.
21. Lygidakis NJ, Berberabe AE, Spentzouris N, et al: Targeting locoregional immunochemotherapy with new drugs in metastatic liver disease: a promising alternative. Hepatogastroenterology 1998; 45(24):2248-2251.
22. Lygidakis NJ, Spentzouris N, Dedemadi G: Resectional liver surgery in metastatic liver disease. Hepatogastroenterology 1998; 45(22):1034-1038.
23. Lygidakis NJ, Thodorakopoulou M, Dedemadi G, et al: Resection of unresectable secondary liver tumors - new frontiers in liver surgery. Hepatogastroenterology 1997; 44(18):1632-1640.
24. Lygidakis NJ, Pearl A: Metastatic liver disease - a review. Hepatogastroenterology 1997; 44(17):1484-1487.
25. Lygidakis NJ, Tsiliakos S, Talaat A, Matsakis G, Tepetes K: Multidisciplinary management of hepatocellular carcinoma. Hepatogastroenterology 1997; 44(13):268-273.
26. Lygidakis NJ, Tsiliakos S: Multidisciplinary management of hepatocellular carcinoma. Hepatogastroenterology 1996; 43(12):1611-1619.
27. Lygidakis NJ, Stringaris K: Locoregional immunochemotherapy transplenic and transtumoral in vivo immunostimulation. Hepatogastroenterology 1996; 43(8):440-447.
28. Lygidakis NJ, Stringaris K, Kokinis K, Lyberopoulos K, Raptis S: Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study. Hepatogastroenterology 1996; 43(7):212-220.
29. Lygidakis NJ, Kosmidis P, Ziras N, Parissis J, Kyparidou E: Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem. J Interferon Cytokine Res. 1995; 15(5):467-472.
30. Lygidakis NJ, Ziras N, Parissis J: Resection versus resection combined with adjuvant pre- and post-operative chemotherapy - immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 1995; 42(2):155-161.
31. Lygidakis NJ, Pothoulakis J, Konstantinidou AE, Spanos H: Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study. Anticancer Res 1995; 15(2):543-550.
32. Lygidakis NJ, Konstantinidou T, Pothoulakis J, et al: Pre- and post-operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative. Anticancer Res 1994; 14(3B):1351-1355.
33. Lygidakis NJ, Savanis G, Pothoulakis J, Kapetanakis A: Transarterial locoregional immunostimulation and chemotherapy in patients with unresectable secondary liver tumours. Anticancer Res 1994; 14(2B):643-646.
34. Lygidakis NJ, Savanis G, Konstantinidou AE, et al: A new look in the management of unresectable primary hepatocellular carcinoma. Hepatogastroenterology 1992; 39(6):577-583.
35. Makuuchi M, Kosuge T, Lygidakis NJ: New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma - an old problem revisited. Hepatogastroenterology 1991; 38(4):329-336.
36. Lygidakis NJ: Primary hepatocellular carcinoma. Hepatogastroenterology 1990; 37(5):439-440.
37. Lencioni R, Cioni D, Donati F, Bartolozzi C: Combination of interventional therapies in hepatocellular carcinoma. Hepatogastroenterology 2001; 48(37):8-14.
38. Kainuma O, Asano T, Aoyama H, et al: Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer. Hepatogastroenterology 1999; 46(26):1071-1077.
39. Tarazov PG, Granov DA, Sergeev VI, et al: Preoperative portal vein embolization for liver malignancies. Hepatogastroenterology 2006; 53(70):566-570.
40. Mathur P, Allen-Mersh TG: Hepatic arterial chemotherapy for colorectal liver metastases. Hepatogastroenterology 2001; 48(38):317-319.
41. Ohmoto K, Yoshioka N, Tomiyama Y, et al: Thermal ablation therapy for hepatocellular carcinoma: comparison between radiofrequency ablation and percutaneous microwave coagulation therapy. Hepatogastroenterology 2006; 53(71):651-654.
42. Shen SQ, Xiang JJ, Xiong CL, Wu SM, Zhu SS: Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC. Hepatogastroenterology 2005; 52(65):1403-1407.
43. Zardi EM, Picardi A, Borzomati D, Coppola R, et al: Radiofrequency ablation of hepatic tissue: a new experimental animal model. Hepatogastroenterology 2004; 51(56):570-574.
44. Ng KK, Lam CM, Poon RT, et al: Radiofrequency ablation as a salvage procedure for ruptured hepatocellular carcinoma. Hepatogastroenterology 2003; 50(53):1641-1643.
45. Lo HW, Tsai YJ, Chen PH, et al: Radiofrequency ablation for treatment of hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 2003; 50(51):645-650.
46. Bartolozzi C, Crocetti L, Cioni D, et al: Assessment of therapeutic effect of liver tumor ablation procedures. Hepatogastroenterology 2001; 48(38):352-358.
47. Montorsi M, Santambrogio R, Bianchi P, et al: Laparoscopic radiofrequency of hepatocellular carcinoma (HCC) in liver cirrhosis. Hepatogastroenterology 2001; 48(37):41-45.
48. Ribeiro MA Jr, Rodrigues JJ, Habr-Gama A, et al: Radiofrequency ablation of primary and metastatic liver tumors - 4 years experience. Hepatogastroenterology 2007; 54(76): 1170-1175.
49. Ohmoto K, Yoshioka N, Tomiyama Y, et al: Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study. Hepatogastroenterology 2007; 54(76):985-989.
50. Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ, Li DM, Lai JM: Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial: Zhonghua Yi Xue Za Zhi 2006; 86(12):801-805.
51. Wakai T, Shirai Y, Suda T, Yokoyama N, Sakata J, Cruz PV, Kawai H, MatsudaY, Watanabe M, Aoyagi Y, Hatakeyama K: Long-term outcomes of hepatectomy vs. percutaneous ablation for treatment of hepatocellular carcinoma less or =4 cm. World J Gastroenterol 2006; 12(4):546-552.
52. Lencioni R, Crocetti L: A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 2005; 9:301-314.
53. Ohmoto K, Miyake I, Tsuduki M, Shibata N, Takesue M, Kunieda T, Ohno S, Kuboki M, Yamamoto S: Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology 1999; 46(29):2894-2900.
54. Haemmerich D, Laeseke PF: Thermal tumour ablation: devices, clinical applications and future directions. Int J Hyperthermia 2005; 21(8):755-756.
55. Chinn SB, Lee FT Jr, Kennedy GD, et al: Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR Am J Roentgenol 2001; 176:789-795.
56. Ibiati L, Ierace T, Goldberg SN, et al: Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195-203.
57. Curley SA, Izzo F, Delrio P, et al: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230:1-8.
58. Crews KA, Kuhn JA, McCarty TM, Fisher TL, Goldstein RM, Preskitt JT: Cryosurgical ablation of hepatic tumors. Am J Surg 1997; 174:614-617.
59. Wong WS, Patel SC, Cruz FS, Gala KV, Turner AF: Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation. Cancer 1998; 82:1268-1278.
60. Seifert JK, Morris DL: Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228:201-208.
61. Pearson AS, Izzo F, Fleming RY, et al: Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999; 178:592-599.
62. Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H: Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997; 225:39-38.
63. Ravikumar TS, Kane R, Cady B, Jenkins R, Clouse M, Steele G Jr: A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 1991; 126:1520-1523.
64. Skinner MG, Iizuka MN, Kolios MC, Sherar MD: A theoretical comparison of energy sources -microwave, ultrasound and laser- for interstitial thermal therapy. Phys Med Biol 1998; 43:3535-3547.
65. Sato M, Watanabe Y, Tokui K, Murakami M, Kohtani T, Kawachi K: A long-term survivor undergoing extensive microwave coagulation for unresectable hepatocellular carcinoma. Hepatogastroenterology 1999; 46(30):3234-3236.
66. Midorikawa T, Kikuchi H, Ishibashi K, Saito M, Hatakeyama T, Kadokura S, Matsumoto T, Miyakawa K, Maezawa K, Uemichi O, Izuno H, Aita K, Nemoto H, Nagasaki H, Yagi H: Microwave coagulation therapy for a liver tumor involving the root of the left hepatic vein of the residual liver after extended right hepatectomy. Hepatogastroenterology 2004; 51(58):1148-1150.
67. Wright AS, Lee FT Jr, Mahvi DM: Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003; 10:275-283.
68. Sato M, Watanabe Y, Ueda S, et al: Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 1996; 110:1507-1514.
69. Abe T, Shinzawa H, Wakabayashi H, et al: Value of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in relation to tumor size and location. Endoscopy 2000; 32:598-603.
70. Seki T, Wakabayashi M, Nakagawa T, et al: Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999; 85:1694-1702.
71. Lu MD, XU HX, Yin XY, et al: Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 2005: 40(11):1054-1060.
72. Xu HX, Xie XY, Lu MD, et al: Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol 2004; 59(1):53-61.
73. Matsukawa T, Yamashita Y, Arakawa A, et al: Percutaneous microwave coagulation therapy in liver tumors. A 3-year experience. Acta Radiol 1997; 38:410-415.
74. Lu MD, Chen JW, Xie XY, et al: Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221:167-172.
75. Wallace JR, Christians KK, Quiroz FA, Foley WD, Pitt HA, Quebbeman EJ: Ablation of liver metastasis: is preoperative imaging sufficiently accurate? J Gastrointest Surg 2001; 5:98-107.
76. Gaitini D, Kopelman D, Soudak M, Epelman M, Assalia A, Hashmonai M, et al: Impact of intraoperative sonography on resection and cryoablation of liver tumors. J Clin Ultrasound 2001; 29:265-272.
77. Tait IS, Yong S, Cuschieri A: Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br J Surg 2002; 89:1613-1619.
78. Jarnagin WR, Bodniewicz J, Dougherty E, Conlon K, Blumgart LH, Fong Y: A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg 2000; 4:34-43.
79. Carrella G, Sortini D, Basaglia E, Marcello D, Carcoforo P, Sortini A, Pozza E: Impact of laparoscopy and ultrasonography in gastrointestinal malignancies. Hepatogastroenterology 2005; 52(61):139-142.
80. Sand J, Marnela K, Airo I, Nordback I: Staging of abdominal cancer by local anesthesia outpatient laparoscopy. Hepatogastroenterology 1996; 43(12):1685-1688.
81. Montorsi M, Santambrogio R, Bianchi P, et al: Perspectives and drawbacks of minimally invasive surgery for hepatocellular carcinoma. Hepatogastroenterology 2002; 49(43):56-61.
82. Lygidakis NJ, Makuuchi M: Clinical application of per-operative ultrasonography in liver surgery. Hepatogastroenterology 1992; 39(3):232-236.
83. Lygidakis NJ, Makuuchi M: Surgical anatomy of the liver in the presence of disease. Possibilities and expectations of perioperative ultrasonography. Hepatogastroenterology 1991; 38(4):321-328.